Page 27 - Common Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alset EHome International Inc. Prices $32.0 Million Underwritten Public Offering of Units ACCESSWIRE BETHESDA, MD / ACCESSWIRE / May 10, 2021 / Alset EHome International Inc. (NASDAQ:AEI) (the 'Company'), a diversified holding company principally engaged through its subsidiaries in property development, digital transformation technology and biohealth activities, today announced the pricing of an underwritten public offering (the 'Offering') of 4,700,637 Units (the 'Common Units'), at a price to the public of $5.07 per Common Unit, with each Common Unit consisting of (a) one share of common s...

Share this article Share this article WHIPPANY, N.J., May 6, 2021 /PRNewswire/ -- Suburban Propane Partners, L.P. (NYSE:SPH), today announced earnings for its second quarter ended March 27, 2021. Net income for the second quarter of fiscal 2021 was $127.2 million, or $2.03 per Common Unit, compared to net income of $77.4 million, or $1.24 per Common Unit, in the prior year second quarter. Adjusted EBITDA (as defined and reconciled below) increased $41.4 million, or 31.7%, to $172.0 million for the second quarter of fiscal 2021, compared to $130.6 million in the prior year second quarter. In ...

- MultiXthin – For Flouroscopy market Voyageur is prepared to test its newly-formulated products under GMP and HC guidelines and advance to clinical testing. Voyageur plans to ensure that it is creating the highest quality products prior to phase one marketing, sales and distribution to Canadian, USA and international markets. Voyageur has begun the process to prepare applications for FDA device registrations. Based on the new regulatory change of barium sulfate being designated as a device, versus its previous designation as a drug, Voyageur plans to move forward with a marketing and sal...

Voyageur Pharmaceuticals Ltd. Issued 4th Health Canada License For Radiographic Barium Contrast Product Brand Story Voyageur Pharmaceuticals Ltd. ( TSX.V:VM) ( OTC:VYYRF) (the 'Company' or 'Voyageur') is pleased to announce that it has received approval from Health Canada (HC) for its product, MultiXthin barium sulfate suspension. MultiXthin is specifically designed for single contrast radiographic examinations of the oesophagus, stomach, and small bowel to visualize the gastrointestinal (GI) tract in adult and pediatric patients. Voyageur has built a suite of barium radiographic contrast me...

Navios Maritime Partners L.P. Reports Financial Results for the First Quarter of 2021 Merger with Navios Maritime Containers L.P. completed on March 31, 2021 Revenue: $65.1 million from Navios Partners $43.7 million from Navios Containers Net cash from operating activities: $27.4 million total net cash from operating activities for Q1 2021 $16.2 million from Navios Partners $11.2 million from Navios Containers Adjusted EBITDA: $33.7 million from Navios Partners $22.7 million from Navios Containers $500.0 million financing Significant fleet expansion $0.05 per unit cash distribution for Q1 20...